EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Proteomic diversity of Russell's viper venom: exploring PLA2 isoforms, pharmacological effects, and inhibitory approaches

Kishore Srinivasan, Madhavan Nampoothiri, Shweta Khandibharad, Shailza Singh, Akshatha Ganesh Nayak, Raghu Chandrashekar Hariharapura iD

Archives of Toxicology · 2024-11 · 98 (11) · 3569-3584

DOI: 10.1007/s00204-024-03849-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archives of Toxicology, online erschienen am 24.08.2024. Verfasst von Kishore Srinivasan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, Indi…. Hauptthemen laut MEDLINE: Phospholipases A2, Daboia, Proteomics, Viper Venoms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Manipal Academy of Higher Education, Manipal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Snakebite envenomation is a serious health concern in tropical regions, resulting in high mortality. The World Health Organization (WHO) has declared it a neglected tropical disease and is working on strategies to reduce mortality. Russell’s viper ( Daboia russelii ) is one of the most abundant venomous snakes found across Southeast Asia. Proteomic analysis of Russell’s viper venom has demonstrated variation, with phospholipase A2 (PLA2) being the most abundant toxin across geographic boundaries. PLA2, a major constituent of the low-molecular-weight fraction of snake venom, hydrolyses phospholipids at the sn-2 position, releasing arachidonic acid and lysophospholipids. They are reported to cause various pharmacological effects, including hemolysis, anticoagulation, neurotoxicity, myotoxicity, and oedema. Though administration of antivenoms (ASV) is the primary treatment for envenomation, it has many drawbacks. Besides causing hypersensitivity reactions and life-threatening anaphylaxis, treatment with ASV is further complicated due to its inability to neutralize low-molecular-weight toxins. Thus, there is a greater need to produce next-generation antivenoms that can target specific toxins in the venom. In this review, we explored the classification of Russell’s viper and the variation in its proteomic profile across Southeast Asia to date. In addition, we have also summarized the mechanism of action of PLA2 and discussed various isoforms of PLA2 found across different regions with their respective pharmacological effects. Finally, the drawbacks of commercially available antivenoms and the molecules investigated for inhibiting the low-molecular-weight toxin, PLA2 are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phospholipases A2DaboiaProteomicsViper VenomsAntiveninsAnimalsHumansSnake BitesIsoenzymes

Stichwörter der Autor:innen

Daboia russeliiAntivenomsLow-molecular-weight toxinsPhospholipase A2Russell’s viper

Substanzen

Phospholipases A2Viper VenomsAntiveninsIsoenzymes

Autor:innen und Institutionen

  • Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
  • Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
  • National Centre for Cell Science, NCCS Complex, Savitribai Phule Pune University Campus, Ganeshkhind, Pune, Maharashtra, India.
  • Division of Biochemistry, Department of Basic Medical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
  • Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India. raghu.c@manipal.edu.

ORCID-Profile: Raghu Chandrashekar Hariharapura

Förderung

  • Manipal Academy of Higher Education, Manipal

Zitieren

APA

Srinivasan, K., Nampoothiri, M., Khandibharad, S., Singh, S., Nayak, A. G., & Hariharapura, R. C. (2024). Proteomic diversity of Russell's viper venom: exploring PLA2 isoforms, pharmacological effects, and inhibitory approaches. Archives of Toxicology, 98(11), 3569-3584. https://doi.org/10.1007/s00204-024-03849-5

Vancouver

Srinivasan K, Nampoothiri M, Khandibharad S, Singh S, Nayak AG, Hariharapura RC. Proteomic diversity of Russell's viper venom: exploring PLA2 isoforms, pharmacological effects, and inhibitory approaches. Archives of Toxicology. 2024;98(11):3569-3584. doi:10.1007/s00204-024-03849-5

BibTeX
@article{Srinivasan2024,
  author = {Srinivasan, Kishore and Nampoothiri, Madhavan and Khandibharad, Shweta and Singh, Shailza and Nayak, Akshatha Ganesh and Hariharapura, Raghu Chandrashekar},
  title = {Proteomic diversity of Russell's viper venom: exploring PLA2 isoforms, pharmacological effects, and inhibitory approaches},
  journal = {Archives of Toxicology},
  year = {2024},
  volume = {98},
  number = {11},
  pages = {3569--3584},
  doi = {10.1007/s00204-024-03849-5}
}
Kostenlos starten →